Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
2(15%)
Results Posted
20%(1 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
5
38%
Ph phase_4
2
15%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(5)
Terminated(3)
Other(3)

Detailed Status

Completed5
unknown3
Terminated3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (28.6%)
N/A5 (71.4%)

Trials by Status

unknown323%
recruiting215%
terminated323%
completed538%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
13